[Translated article] Dermatology Update on the Challenging Trichodynia
Actas Dermo-Sifiliográficas · 2025
DOI: 10.1016/j.ad.2025.07.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Actas Dermo-Sifiliográficas, 2025. Verfasst von G Rodriguez-Tamez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Dermatología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico. Hauptthemen laut MEDLINE: Pain, Scalp. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Trichodynia is the sensation of pain in the scalp, which, in most cases, is associated with certain types of alopecia. Despite being a term coined by Rebora back in 1996 to described patients with diffuse alopecia consistent with telogen effluvium, this symptom has currently been reported in other entities. Androgenic alopecia, scarring alopecia, alopecia areata, trichotillomania, and chemotherapy-induced alopecia are common causes of trichodynia. Similarly, its association with psychiatric comorbidities, including depression, anxiety, obsessive-compulsive disorder and somatoform disorders has been reported with a higher prevalence among women. Although its pathogenesis is still to be elucidate, some factors involved are substance P, psychiatric comorbidities and perifollicular inflammation. Clinically it exhibits pain or discomfort of the scalp, almost always in association with hair loss. The sensation of pain can occur throughout the scalp or locally in some specific areas. Diagnosis is clinical and one of exclusion. Regarding treatment, there are no specific therapies for trichodynia. However, the use of botulinum toxin A, antidepressants, neuromodulators, propranolol, topical corticosteroids, oral corticosteroids and topical cannabinoids are therapeutic alternatives that should be taken into consideration. Since treatment of trichodynia is still therapeutically challenging for dermatologists more prospective studies are needed to evaluate new therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servicio de Dermatología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
- Servicio de Dermatología, Hospital Universitario Severo Ochoa, Madrid, Spain; Hair Disorders Unit, Grupo de Dermatología Pedro Jaén, Madrid, Spain. Electronic address: dradrianimbernon@gmail.com.
- Hair Disorders Unit, Grupo de Dermatología Pedro Jaén, Madrid, Spain; Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Departamento de Biología de Sistemas, Facultad de Medicina, Universidad de Alcalá, IR…
Zitieren
APA
Rodriguez-Tamez, G., Imbernon-Moya, A., Saceda-Corralo, D., & Vano-Galvan, S. (2025). [Translated article] Dermatology Update on the Challenging Trichodynia. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2025.07.006
Vancouver
Rodriguez-Tamez G, Imbernon-Moya A, Saceda-Corralo D, Vano-Galvan S. [Translated article] Dermatology Update on the Challenging Trichodynia. Actas Dermo-Sifiliográficas. 2025. doi:10.1016/j.ad.2025.07.006
BibTeX
@article{RodriguezTamez2025,
author = {Rodriguez-Tamez, G and Imbernon-Moya, A and Saceda-Corralo, D and Vano-Galvan, S},
title = {[Translated article] Dermatology Update on the Challenging Trichodynia},
journal = {Actas Dermo-Sifiliográficas},
year = {2025},
doi = {10.1016/j.ad.2025.07.006}
}
EUVIMED